(Q73229276)
Statements
Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty (English)
Jochen Wöhrle
Olaf C Grebe
Thorsten Nusser
Eyas Al-Khayer
Stefan Schaible
Matthias Kochs
Vinzenz Hombach